Problemática y soluciones actuales en el tratamiento de las infecciones por microorganismos grampositivos

Grau, Santiago; Álvarez Lerma, Francisco; Marín, Mónica; Gimeno, Juan Luis.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 19(8): 393-398, oct. 2001.
Artículo en Es | IBECS (España) | ID: ibc-2965

Documentos relacionados

  1. Antimicrobial Susceptibility Testing for Enterococci.
  2. Comparing the pharmacokinetics and organ/tissue distribution of anti-methicillin-resistant <i>Staphylococcus aureus</i> agents using a rat model of sepsis.
  3. High occurrence of <i>Enterococcus faecalis</i>, <i>Enterococcus faecium</i>, and <i>Vagococcus lutrae</i> harbouring oxazolidinone resistance genes in raw meat-based diets for companion animals - a public health issue, Switzerland, September 2018 to May 2020.
  4. Oxazolidinones: mechanisms of resistance and mobile genetic elements involved.
  5. The first case of teeth discoloration induced by linezolid in children in China Mainland.
  6. Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.
  7. A pharmacokinetic-pharmacodynamic (PKPD) model-based analysis of tedizolid against enterococci using the hollow-fibre infection model.
  8. Advances in contezolid: novel oxazolidinone antibacterial in Gram-positive treatment.
  9. Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.
  10. Vancomycin-resistant enterococcal bacteremia pharmacotherapy.